Nimble Science Ltd.

Nimble Science Ltd. is a Canadian life-sciences company based in Calgary, Alberta, that is commercializing a novel approach to gastrointestinal microbiome sampling. Its core offering is the SIMBA GI Platform, built around the SIMBA capsule — an ingestible device designed to autonomously transit the gastrointestinal tract, collect a fluid biopsy from the small intestine, and seal and preserve the sample in vivo at the point of collection. The company positions this as "Precision Access for Precision Medicine," a multi-omic data platform intended to transform GI care "from plate to bedside." The scientific premise behind Nimble Science is that stool-based microbiome analysis insufficiently characterizes the small intestine, which plays a critical role in digestion, nutrient absorption, gut–brain signaling, and immune maintenance. The company states that over 2,000 differences have been found among bacterial communities in stool collection compared with collections focused on the small intestine, and it markets the SIMBA capsule as a way to complete a microbiome dataset with small-intestinal data. Nimble Science sells into research and clinical-study markets rather than as a diagnostic product. The SIMBA capsule is authorized for use in Investigational Testing by federal regulatory bodies and does not provide diagnostic information. The company supports biopharma and nutrition clients with study design, technical guidance, kit shipment, sample processing, and multi-omic analysis including metagenomics, metabolomics, and proteomics. It also operates a Data Partnerships program that offers discounted access to SIMBA capsule kits in exchange for specific data rights, and it works with certified service providers in North America and Europe, including Cmbio, NIZO Food Research, and Seqbiome. Nimble Science is a private company. Public evidence identifies it as a company in Calgary, Canada, but does not disclose founding year, founders, ownership, or funding details. Its website and service pages describe an active commercial operation focused on enabling small-intestinal multi-omic datasets for microbiome research, product validation, fecal transplant research, and disease-state correlation.

Nimble Science Ltd. is a Canadian company based in Calgary, Alberta, focused on gastrointestinal microbiome sampling technology. Public evidence does not specify its founding year or founders, but its official website and service pages describe an active commercial operation centered on the SIMBA GI Platform and the SIMBA capsule. The company's core innovation is an ingestible capsule that autonomously transits the gastrointestinal tract to collect, seal, and preserve a multi-omic fluid biopsy from the deepest regions of the small intestine. This addresses a recognized limitation in microbiome research: stool samples insufficiently characterize the microbial composition of the small intestine. Nimble Science states that over 2,000 differences have been found among bacterial communities in stool collection compared with collections focused on the small intestine. Nimble Science markets the SIMBA capsule for use in clinical studies rather than as a diagnostic device. The capsule is authorized for use in Investigational Testing by federal regulatory bodies and does not provide diagnostic information. The company supports biopharma and nutrition clients with study design, protocol development, ethics submission support, training, sample handling know-how, kit shipment, and sample processing. The SIMBA capsule kits are processed by Nimble or one of its service partners to ensure uncontaminated sample removal and high-quality sequencing, and can be analyzed for multi-omic datasets including metagenomics, metabolomics, and proteomics. To expand its ecosystem, Nimble Science works with certified service providers in North America and Europe. Named partners include Cmbio, a multi-omics and digital biology company formed through the merger of Clinical Microbiomics with CosmosID, MS-Omics, DNASense, and Microba's Research Service Unit; NIZO Food Research B.V., a contract research organization based in Ede, the Netherlands; and Seqbiome, a spin-out from APC Microbiome in Ireland. Nimble Science also operates a Data Partnerships program that offers discounted access to SIMBA capsule kits in exchange for specific data rights, supporting research entities and commercial partners seeking to validate or evaluate interventional products. The company maintains a growing database of healthy and unhealthy fecal and small intestinal sample sets to help clients plan studies and reference results. Its stated mission is to bring clients next-generation GI health data insights to advance research and support innovation in personalized healthcare.

Precision Access for Precision Medicine — a multi-omic data platform to transform GI care from plate to bedside.

• SIMBA capsule

  An ingestible capsule that autonomously transits the GI tract to collect, seal, and preserve a multi-omic fluid biopsy from the deepest regions of the small intestine. Authorized for use in Investigational Testing by federal regulatory bodies; does not provide diagnostic information.

• SIMBA GI Platform

  A multi-omic data platform that delivers datasets from the whole GI tract, including the small intestine, for applications such as monitoring treatment-induced changes, validating product-induced microbiome changes, advancing fecal transplant treatments, and correlating multi-omic profiles with disease states.

1. 1Home | Nimble Science | small intestine sampling technologynimblesci.com
2. 2Global Delivery Partners | Nimble Sciencenimblesci.com
3. 3Data Partnerships | Nimble Sciencenimblesci.com
4. 4Biopharma and Nutrition Services | Nimble Sciencenimblesci.com
5. 5Nimble Science Ltd. (Canada) - Wikidatawikidata.org